Sofosbuvir/velpatasvir Interactions
There are 197 drugs known to interact with sofosbuvir/velpatasvir, along with 3 disease interactions. Of the total drug interactions, 46 are major, 145 are moderate, and 6 are minor.
- View all 197 medications that may interact with sofosbuvir/velpatasvir
- View sofosbuvir/velpatasvir disease interactions (3)
Most frequently checked interactions
View interaction reports for sofosbuvir / velpatasvir and the medicines listed below.
- Abilify Maintena (aripiprazole)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Adzynma (apadamtase alfa, recombinant)
- Afrin (oxymetazoline nasal)
- Aimovig (erenumab)
- Aldactone (spironolactone)
- Amondys 45 (casimersen)
- Aspirin Low Strength (aspirin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Claritin (loratadine)
- Crestor (rosuvastatin)
- Descovy (emtricitabine / tenofovir alafenamide)
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- Evenity (romosozumab)
- Fosamax (alendronate)
- Linzess (linaclotide)
- Mounjaro (tirzepatide)
- Neurobion (multivitamin)
- Paracetamol (acetaminophen)
- Prolia (denosumab)
- Suboxone (buprenorphine / naloxone)
- Symbicort (budesonide / formoterol)
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Zoloft (sertraline)
Sofosbuvir/velpatasvir disease interactions
There are 3 disease interactions with sofosbuvir / velpatasvir which include:
Report options
QR code containing a link to this page
More about sofosbuvir / velpatasvir
- sofosbuvir/velpatasvir consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (419)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
